Neuromodulation: Driving Forces Behind the Rapidly Growing Market

https://www.marketsandmarkets.com/Market-Reports/neurostimulation-devices-market-921.html

The global neuromodulation market is projected to reach USD 11.0 billion by 2028 from USD 6.2 billion in 2023, at a CAGR of 12.0% during the forecast period. The neuromodulation market is driven by the increasing incidence of neurological disorders and nerve injuries, the growing geriatric population and subsequent increase in the prevalence of neurological disorders, government support for research on neurological disorders, collaborations among device manufacturers, healthcare providers, and research institutions to develop neuromodulation devices.

The top players in neuromodulation market are Medtronic, Plc (Ireland), Boston Scientific Corporation (US), and Abbott Laboratories (US). These players hold leading positions in the market owing to their broad product offerings in the neuromodulation market. These mentioned players have undertaken various organic and inorganic strategies such as product launches, product approval, acquisitions, collaboration and agreements.